Mitomics Announces U.S. Sales and Marketing Agreement with LabMD

THUNDER BAY, Ontario--(BUSINESS WIRE)--Mitomics, focused on the research and development of mitochondrial genome-based products, announced a non-exclusive agreement with LabMD, a clinical pathology laboratory, to market PCMT in the U.S.

Feed Date: 
February 14, 2012